ENSG The Ensign Group, Inc.

Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle.

Carillon Tower Advisers, an investment management company, released its second-quarter 2026 investor letter for the “Carillon Eagle Small Cap Growth Fund”. The letter can be downloaded here. Small-cap stocks rallied broadly in the second quarter, with the Russell 2000 Growth Index (+25.71%) outpacing Value +17.24%). Information Technology (+46.79%) led all sectors, supported by solid gains […]

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Ensign Group (ENSG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

ENSG's decentralized model is driving organic growth through higher occupancy, stronger clinical results and improved productivity across its facilities.

Ensign Group stock has delivered a strong 115.2% return over the past 5 years, while a Discounted Cash Flow (DCF) intrinsic value estimate currently points to the shares trading at about a 13% discount. This contrasts with a low overall value score that leans more expensive on broader checks. The 115.2% return over 5 years suggests Ensign Group has already rewarded long term holders, so any case for value today needs to clear a higher bar. On the supportive side, the enlarged US$800m credit...

Ensign Group (ENSG) has just made two governance and financing moves that matter for shareholders. Freshly amended bylaws and an expanded revolving credit facility now frame how the company runs meetings and funds future capital needs. At a share price of $173.20, Ensign Group has seen recent momentum cool slightly, with the 7 day share price return down 3.25% and the 30 day share price return down 2.78%. However, the 3 year total shareholder return of 82.21% and 5 year total shareholder...

Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at The Ensign Group (NASDAQ:ENSG) and its peers.

Ensign Group's rising occupancy, acquisitions and real-estate growth support its outlook, while reimbursement and cost pressures remain risks.

Ensign Group (ENSG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Boot Barn, Five Below, The Ensign and GE HealthCare have been highlighted in this Screen of The Week article.

Investors need to pay close attention to ENSG stock based on the movements in the options market lately.

Over the past six months, The Ensign Group’s stock price fell to $182.42. Shareholders have lost 10.9% of their capital, which is disappointing considering the S&P 500 has climbed by 12.9%. This might have investors contemplating their next move.

PACS Group shares have rebounded after a Medicare billing scandal, with strong Q2 earnings and Buy ratings, though DOJ and SEC investigations and shareholder lawsuits remain unresolved.

Stocks that outperform the market usually share key traits such as rising sales, expanding margins, and increasing returns on capital. The select few that can do all three for many years are often the ones that make you life-changing money.

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 16.6% over the past six months, topping the S&P 500 by 9.6 percentage points.

Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with competition, ranging from giants with vast resources to agile upstarts eager to disrupt the status quo.

Earnings beat and guidance raise put Ensign Group in focus Ensign Group (ENSG) just reported Q2 2026 results and raised its full-year earnings and revenue guidance, putting the stock on many investors' watchlists as they reassess expectations. The company now guides to 2026 diluted earnings of US$7.75 to US$7.85 per share and revenue of US$5.87b to US$5.92b, citing the strength of second quarter trading as the basis for the higher ranges. See our latest analysis for Ensign Group. Ensign...

Ensign Group beats Q2 earnings and raises its 2026 outlook as higher occupancy, patient days and acquired facilities drive revenue growth.

Ensign Group Inc (ENSG) reports a 20.8% increase in adjusted EPS and raises full-year guidance, driven by strong operational momentum and strategic acquisitions.

The Ensign Group (NASDAQ:ENSG) raised its 2026 earnings and revenue outlook after reporting second-quarter gains in revenue, earnings and occupancy, while highlighting continued acquisition activity and clinical quality measures across its skilled nursing portfolio. For the second quarter, the comp

Companies in The News Are: ENSG,HOPE,LKFN,HBT

Shares of healthcare services company The Ensign Group (NASDAQ:ENSG). jumped 4.9% in the morning session after the company issued an upbeat full-year outlook that overshadowed its mixed second-quarter results, which missed analyst estimates on both revenue and earnings.

Wasatch Global Investors, an asset management company, released its “Small Cap Growth Strategy” Q2 2026 investor letter. A copy of the letter can be downloaded here. Small-cap equities experienced strong gains in the second quarter, primarily driven by companies associated with artificial intelligence (AI). However, the leadership within this sector remains narrow. Unprofitable companies and those […]

Although the revenue and EPS for Ensign Group (ENSG) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

The Ensign Group Inc. (NASDAQ:ENSG) reported second-quarter results that exceeded Wall Street expectations on Monday, prompting the healthcare operator to raise its financial guidance for the full year.

Healthcare services company The Ensign Group (NASDAQ:ENSG). fell short of the market’s revenue expectations in Q2 CY2026, but sales rose 10.7% year on year to $1.44 billion. On the other hand, the company’s full-year revenue guidance of $5.90 billion at the midpoint came in 0.9% above analysts’ estimates. Its GAAP profit of $1.68 per share was 2.2% below analysts’ consensus estimates.

Ensign Group (ENSG) delivered earnings and revenue surprises of +6.67% and +0.63%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.

ClearBridge Investments, a global equity manager, recently published second-quarter 2026 commentary for its “SMID Cap Growth Strategy”. A copy can be downloaded here. Small and mid-cap (SMID) growth equities experienced the strongest quarter in recent memory, with the Russell 2500 Growth Index rising 24.0%, driven by enthusiasm for AI infrastructure and higher-beta momentum stocks. The […]